Concepedia

Cara A. Rabik

CA

Statistics

Publications

13

Citations

616

H-Index

13

Active since

2005

Affiliations

Stanford University(Current)

Children's Mercy Hospital

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

UCSF Benioff Children's Hospital

Memorial Sloan Kettering Cancer Center

Cara A. Rabik is an author at Stanford University specializing in medicine, cell transplantation, and immunotherapy.

ORCID

Top concepts

Publications per year

2005–2023

13

Publications

13

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen et al. · Blood Advances · 2021 · 103 citations · Full text

, , +19

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane et al. · Blood Advances · 2021 · 74 citations · Full text

, , +18

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Liora M. Schultz, Anne Eaton, Christina Baggott et al. · Journal of Clinical Oncology · 2022 · 71 citations · Full text

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

Amy Moskop, Lauren Pommert, Christina Baggott et al. · Blood Advances · 2022 · 61 citations · Full text

, , +20

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

Heather E. Stefanski, Anne Eaton, Christina Baggott et al. · Blood Advances · 2022 · 50 citations · Full text

1–5 of 13